Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want to preserve or restore fertility, are younger, or have low testosterone due to a central (secondary) cause → try a gonadotropin‑stimulating approach first (enclomiphene or more commonly clomiphene or hCG).
• If you have testicular failure (primary hypogonadism), are older, don’t want fertility, or need rapid reliable symptom control → start testosterone replacement therapy (TRT).

Why (brief)

• Enclomiphene (a selective estrogen receptor modulator that raises LH/FSH) stimulates your own testes to make testosterone and generally preserves or increases sperm production. That makes it the preferred first choice for men who want future fertility or who have secondary hypogonadism.
• TRT (exogenous testosterone: gels, injections, long‑acting IM) reliably relieves symptoms and raises testosterone, but it suppresses LH/FSH and usually reduces sperm counts — so it impairs fertility and can be harder to reverse quickly.

Practical factors to check first

1. Labs: at least two early‑morning total testosterone measurements, plus LH and FSH (and prolactin if LH/FSH low). This tells you primary vs secondary hypogonadism.
2. Symptoms and goals: fertility desired? severity of symptoms? comorbidities?
3. Baseline safety tests before TRT: CBC, hematocrit, PSA (age‑appropriate), lipids, LFTs, metabolic panel.

Drug options and notes (brands/examples)

• Enclomiphene: studied for male hypogonadism and works like clomiphene, but it is not widely available in every country/market. Brand name in clinical development was Androxal. Availability can be limited; discuss with a specialist.
• Clomiphene citrate (commonly used off‑label in men): Clomid — widely used alternative to stimulate endogenous testosterone and preserve fertility.
• hCG (if you want to maintain/increase spermatogenesis while taking TRT or instead of TRT): Pregnyl, Novarel or Ovidrel (brands vary by country) — used by urologists/reproductive endocrinologists.
• TRT formulations (if chosen): topical gels (AndroGel, Testim, Fortesta), transdermal patch (Androderm), short‑acting IM injections (Depo‑Testosterone — testosterone cypionate/enanthate), long‑acting IM (Aveed — testosterone undecanoate in the US; Nebido in some countries). Choose formulation based on cost, convenience, dosing frequency, and side‑effect profile.

Risks/monitoring — quick summary

• Enclomiphene/clomiphene: usually preserves fertility; common side effects can include mood changes, visual symptoms (rare), and estrogen‑related effects. Need periodic testosterone and LH/FSH checks.
• TRT: effective symptom relief; risks include erythrocytosis (monitor hematocrit), acne, possible prostate growth/PSA rise (monitor), decreased sperm count/fertility, and need for ongoing therapy and monitoring.

How to decide (simple algorithm)

1. Get morning total T + LH/FSH.
2. If LH/FSH high → primary hypogonadism → discuss TRT.
3. If LH/FSH low/normal → secondary hypogonadism → consider enclomiphene/clomiphene or hCG first, especially if fertility matters.
4. If older or don’t want fertility or if stimulatory therapy fails → TRT.

Next steps I recommend

• Get baseline labs (AM total T x2, LH, FSH, CBC, PSA if >40, metabolic panel).
• See an endocrinologist or urologist (or a reputable men’s health telemedicine service) to interpret results and choose a regimen.
• If fertility is a concern, explicitly tell the clinician — that typically steers treatment away from TRT up front.

If you want, tell me your age, morning testosterone result(s), LH/FSH, and whether you want children — I can give a more specific recommendation.